Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
AstraZeneca announces baxdrostat met primary endpoint in Bax24 Phase III trial
3h ago
AZN
Premium
The Fly
Midday Fly By: Musk pay plan approved, ‘GTA VI’ delayed
2d ago
BL
BX
Premium
The Fly
AstraZeneca CEO warns U.K. faces generics-only future, Guardian reports
3d ago
AZN
Premium
The Fly
AstraZeneca reports statistical significance in NATRON trial
3d ago
AZN
Premium
The Fly
Avenue Therapeutics announces Baergic Bio acquisition by Axsome
4d ago
AZN
ATXI
Premium
The Fly
Axsome enters agreement to obtain exclusive global rights to AZD7325
4d ago
AZN
ATXI
Premium
The Fly
AstraZeneca reports Q3 core EPS $2.38, consensus $1.09
4d ago
AZN
Premium
The Fly
AstraZeneca backs FY25 core EPS view up low double-digit percentage
4d ago
AZN
Premium
Ratings
AstraZeneca: Strong Financial Performance and Promising Pipeline Support Buy Rating
4d ago
AZN
Premium
The Fly
AstraZeneca reports Q3 core EPS $2.38, up 12% at CER
4d ago
AZN
Premium
The Fly
AstraZeneca sees FY25 core EPS increasing by low double-digit percentage
4d ago
AZN
Premium
Company Announcements
AstraZeneca Reports Robust 2025 Growth and Strategic US Expansion
4d ago
Premium
The Fly
AstraZeneca holders approve listing in London, NYC and Stockholm
6d ago
AZN
Premium
Company Announcements
AstraZeneca Shareholders Approve Harmonized Listing Structure
6d ago
Premium
Company Announcements
AstraZeneca Announces Current Voting Rights and Share Capital Details
7d ago
Premium
The Fly
AstraZeneca, Daiichi Sankyo dose first patient in DESTINY-Lung06 trial
10d ago
AZN
Premium
The Fly
AstraZeneca reports gefurulimab met primary endpoint in PREVAIL Phase 3 trial
10d ago
AZN
Premium
The Fly
FDA moves to accelerate biosimilar development, lower drug costs
11d ago
AZN
BMY
Premium
The Fly
AstraZeneca’s Koselugo approved in EU for plexiform neurofibromas
13d ago
AZN
Premium
Company Announcements
AstraZeneca’s Koselugo Gains EU Approval for Adult NF1 Treatment
13d ago
Premium
The Fly
Actinium Pharmaceuticals’ ATNM-400 shows superior anti-tumor activity
14d ago
AZN
JNJ
Premium
The Fly
AstraZeneca assumed with a Buy at Jefferies
14d ago
AZN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
